======= ABR =======
== Gene Information ==
* **Official Symbol**: ABR
* **Official Name**: ABR activator of RhoGEF and GTPase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29|29]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q12979|Q12979]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ABR&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ABR|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600365|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a protein that is similar to the protein encoded by the breakpoint cluster region gene located on chromosome 22. The protein encoded by this gene contains a GTPase-activating protein domain, a domain found in members of the Rho family of GTP-binding proteins. Functional studies in mice determined that this protein plays a role in vestibular morphogenesis. Alternatively spliced transcript variants have been reported for this gene. [provided by RefSeq, Feb 2012].
* **UniProt Summary**: N/A
|RhoGAP|
|PH|
|C2|
|RhoGEF|
|negative regulation of neutrophil degranulation|
|negative regulation of blood vessel remodeling|
|negative regulation of neutrophil activation|
|regulation of neutrophil degranulation|
|regulation of blood vessel remodeling|
|negative regulation of cellular extravasation|
|regulation of neutrophil activation|
|negative regulation of myeloid leukocyte mediated immunity|
|negative regulation of leukocyte degranulation|
|postsynaptic density, intracellular component|
|negative regulation of tissue remodeling|
|negative regulation of regulated secretory pathway|
|regulation of cellular extravasation|
|negative regulation of exocytosis|
|regulation of vascular permeability|
|negative regulation of leukocyte migration|
|negative regulation of leukocyte mediated immunity|
|regulation of leukocyte degranulation|
|neuromuscular process controlling balance|
|regulation of myeloid leukocyte mediated immunity|
|positive regulation of phagocytosis|
|Rho guanyl-nucleotide exchange factor activity|
|regulation of tissue remodeling|
|Schaffer collateral - CA1 synapse|
|regulation of phagocytosis|
|activation of GTPase activity|
|inner ear morphogenesis|
|guanyl-nucleotide exchange factor activity|
|neuromuscular process|
|ear morphogenesis|
|negative regulation of immune effector process|
|negative regulation of inflammatory response|
|regulation of Rho protein signal transduction|
|negative regulation of immune response|
|regulation of regulated secretory pathway|
|vascular process in circulatory system|
|negative regulation of leukocyte activation|
|inner ear development|
|regulation of leukocyte migration|
|negative regulation of cell activation|
|negative regulation of secretion by cell|
|regulation of leukocyte mediated immunity|
|negative regulation of defense response|
|ear development|
|regulation of exocytosis|
|negative regulation of secretion|
|regulation of Ras protein signal transduction|
|sensory organ morphogenesis|
|negative regulation of cell migration|
|negative regulation of cell motility|
|GTPase activator activity|
|embryonic organ morphogenesis|
|negative regulation of cellular component movement|
|response to lipopolysaccharide|
|small GTPase mediated signal transduction|
|negative regulation of locomotion|
|response to molecule of bacterial origin|
|regulation of inflammatory response|
|regulation of small GTPase mediated signal transduction|
|glutamatergic synapse|
|negative regulation of response to external stimulus|
|blood circulation|
|circulatory system process|
|positive regulation of GTPase activity|
|embryonic organ development|
|negative regulation of immune system process|
|modulation of chemical synaptic transmission|
|regulation of trans-synaptic signaling|
|regulation of immune effector process|
|regulation of GTPase activity|
|negative regulation of transport|
|actin cytoskeleton organization|
|sensory organ development|
|regulation of vesicle-mediated transport|
|embryonic morphogenesis|
|actin filament-based process|
|regulation of leukocyte activation|
|regulation of cell activation|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|response to bacterium|
|positive regulation of cell death|
|brain development|
|regulation of secretion by cell|
|regulation of defense response|
|positive regulation of hydrolase activity|
|head development|
|regulation of secretion|
|regulation of cell migration|
|response to lipid|
|regulation of cell motility|
|negative regulation of developmental process|
|animal organ morphogenesis|
|embryo development|
|central nervous system development|
|regulation of locomotion|
|positive regulation of transport|
|regulation of cellular component movement|
|regulation of anatomical structure morphogenesis|
|regulation of response to external stimulus|
|cytoskeleton organization|
|regulation of immune response|
|negative regulation of multicellular organismal process|
|regulation of hydrolase activity|
|response to other organism|
|response to external biotic stimulus|
|G protein-coupled receptor signaling pathway|
|response to biotic stimulus|
|nervous system process|
|positive regulation of catalytic activity|
|regulation of response to stress|
|regulation of apoptotic process|
|response to oxygen-containing compound|
|regulation of programmed cell death|
|negative regulation of response to stimulus|
|regulation of immune system process|
|regulation of cell death|
|intracellular signal transduction|
|positive regulation of molecular function|
|regulation of intracellular signal transduction|
|regulation of transport|
|system process|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|-2.02|
|[[:results:exp156|UNC2400 2μM R03 exp156]]|-1.72|
|[[:results:exp539|42°C R08 exp539]]|1.88|
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.93|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13254
* **Expression level (log2 read counts)**: 2.18
{{:chemogenomics:nalm6 dist.png?nolink |}}